Clinical Trial

Clinical Study on the Safety and Preliminary Efficacy of CDH17/GUCY2C CAR-T in the Treatment of Patients With Advanced Colorectal Cancer

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
Due to corporate strategic adjustment.
Summary
This study is a single-arm, single-center investigator-initiated trial (IIT) designed to evaluate the safety and preliminary efficacy of CDH17/GUCY2C CAR-T cell therapy in patients with advanced colorectal cancer, as well as to assess its pharmacodynamic (PD) and pharmacokinetic (PK) profiles.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-26.
Status change: Recruiting → Withdrawn 2026-05-26
Trial Details
NCT Number NCT07152210
Lead Sponsor Guangzhou Bio-gene Technology Co., Ltd
Conditions Colorectal Cancer (CRC)
Start Date 2024-12-11
Primary Completion 2026-03-02 (estimated)
Study Completion 2026-03-02 (estimated)
Updated on ClinicalTrials.gov 2026-05-28